BlackRock’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$305K Sell
508,000
-58,905
-10% -$35.4K ﹤0.01% 4498
2025
Q1
$153K Sell
566,905
-26,421
-4% -$7.13K ﹤0.01% 4610
2024
Q4
$309K Buy
593,326
+25,446
+4% +$13.2K ﹤0.01% 4481
2024
Q3
$1.84M Sell
567,880
-5,434
-0.9% -$17.6K ﹤0.01% 3973
2024
Q2
$1.72M Sell
573,314
-4,874
-0.8% -$14.6K ﹤0.01% 3957
2024
Q1
$2.69M Buy
578,188
+5,445
+1% +$25.3K ﹤0.01% 3838
2023
Q4
$2.37M Sell
572,743
-1,364
-0.2% -$5.65K ﹤0.01% 3904
2023
Q3
$1.72M Sell
574,107
-31,147
-5% -$93.4K ﹤0.01% 3994
2023
Q2
$1.49M Sell
605,254
-1,233,163
-67% -$3.03M ﹤0.01% 4088
2023
Q1
$4.15M Sell
1,838,417
-24,725
-1% -$55.9K ﹤0.01% 3632
2022
Q4
$6.5M Sell
1,863,142
-290,186
-13% -$1.01M ﹤0.01% 3533
2022
Q3
$79.7M Buy
2,153,328
+417
+0% +$15.4K ﹤0.01% 2095
2022
Q2
$40.9M Buy
2,152,911
+200,103
+10% +$3.8M ﹤0.01% 2591
2022
Q1
$52.7M Buy
1,952,808
+567,573
+41% +$15.3M ﹤0.01% 2514
2021
Q4
$31.2M Buy
1,385,235
+174,994
+14% +$3.94M ﹤0.01% 2946
2021
Q3
$31.7M Sell
1,210,241
-259,866
-18% -$6.81M ﹤0.01% 2925
2021
Q2
$47.1M Sell
1,470,107
-18,068
-1% -$578K ﹤0.01% 2701
2021
Q1
$52.4M Sell
1,488,175
-4,844
-0.3% -$171K ﹤0.01% 2545
2020
Q4
$47.9M Buy
1,493,019
+280,318
+23% +$8.99M ﹤0.01% 2455
2020
Q3
$45.6M Sell
1,212,701
-4,064
-0.3% -$153K ﹤0.01% 2308
2020
Q2
$54.4M Buy
1,216,765
+738,752
+155% +$33.1M ﹤0.01% 2176
2020
Q1
$16.3M Buy
478,013
+334,900
+234% +$11.4M ﹤0.01% 2672
2019
Q4
$5.58M Buy
+143,113
New +$5.58M ﹤0.01% 3421